Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).
Wang H, Chen J, Zhang X, Sheng X, Chang XY, Chen J, Chen MS, Dong H, Duan GJ, Hu HP, Huang ZY, Jia WD, Jiang XQ, Kuang D, Li SS, Li ZS, Lu CL, Qin SK, Qiu XS, Qu LJ, Shao CK, Shen F, Shi GM, Shi SS, Shi YJ, Sun HC, Teng XD, Wang B, Wang ZB, Wen TF, Yang JM, Yang QQ, Ye SL, Yin HF, Yuan ZG, Yun JP, Zang FL, Zhang HQ, Zhang LH, Zhao JM, Zhou J, Zhou WX, Fan J, Chen XP, Lau WY, Ji Y, Cong WM; Chinese Society of Liver Cancer of Chinese Anti-Cancer Association; Digestive Disease Group of Chinese Society of Pathology, Chinese Medical Association; Chinese Society of Pathology of Chinese Anti-Cancer Association; Hepatic Surgery Group of Chinese Society of Surgery, Chinese Medical Association; Biliary Tract Tumor Committee of China Anti-Cancer Association; Chinese Society of Clinical Oncology. Wang H, et al. Among authors: yin hf. J Clin Transl Hepatol. 2023 Dec 28;11(7):1553-1564. doi: 10.14218/JCTH.2023.00118. Epub 2023 Jul 24. J Clin Transl Hepatol. 2023. PMID: 38161496 Free PMC article.
Safety and efficacy of radiotherapy combined with lenvatinib plus PD-1 inhibitors as neo-adjuvant therapy in hepatocellular carcinoma with portal vein thrombus: protocol of an open-label, single-arm, prospective, multi-center phase I trial.
Li G, Shu B, Zheng Z, Yin H, Zhang C, Xiao Y, Yang Y, Yan Z, Zhang X, Yang S, Li G, Dong J. Li G, et al. Front Oncol. 2022 Nov 24;12:1051916. doi: 10.3389/fonc.2022.1051916. eCollection 2022. Front Oncol. 2022. PMID: 36505833 Free PMC article.
[Bronchoscopic manifestations and interventional treatment of pulmonary mucormycosis].
Zeng P, Mu XD, Wang LJ, Guo WJ, Zhao JQ, Yin HF, Yao JJ, Wu HX, Lin LJ, Liu XM, Ma XX, Wang HM, Zhao YL. Zeng P, et al. Among authors: yin hf. Zhonghua Jie He He Hu Xi Za Zhi. 2023 Feb 12;46(2):151-157. doi: 10.3760/cma.j.cn112147-20220517-00415. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 36740375 Chinese.
[Clinicopathological features of spinal solitary fibrous tumor].
Ge HJ, Yao JJ, Li L, Li BW, Ge C, Liu H, Li Y, Yin HF. Ge HJ, et al. Among authors: yin hf. Zhonghua Bing Li Xue Za Zhi. 2022 Sep 8;51(9):875-880. doi: 10.3760/cma.j.cn112151-20220128-00069. Zhonghua Bing Li Xue Za Zhi. 2022. PMID: 36097905 Chinese.
68 results